Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/29/2012 | WO2012159522A1 Canine influenza recombinant virus, preparation method therefor and application thereof |
11/29/2012 | WO2012159199A1 Production of soy protein product |
11/29/2012 | WO2012159196A1 Plants having enhanced abiotic stress resistance |
11/29/2012 | WO2012159187A2 Denv-derived peptides and methods for the inhibition of the flavivirus replication |
11/29/2012 | WO2012139046A3 Signal amplification methods for the imaging of protein synthesis and neurotransmitter transport |
11/29/2012 | WO2012136909A3 Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof |
11/29/2012 | WO2012135659A3 Methods for enhancing the degradation or conversion of cellulosic material |
11/29/2012 | WO2012127289A8 R2r1/2 in diagnosis and therapy |
11/29/2012 | WO2012125623A3 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy |
11/29/2012 | WO2012118349A3 Differentiation and proliferation method for natural killer cells from cd14-positive monocytes |
11/29/2012 | WO2012098281A3 Trp-receptor-modulating peptides and uses thereof |
11/29/2012 | WO2012085891A3 Tnf family ligand variants |
11/29/2012 | US20120304337 Endotoxins having nematocidal activity and methods of use thereof |
11/29/2012 | US20120302736 Method for Recovering Bowman-Birk Inhibitor Proteins from a Soy Processing Stream |
11/29/2012 | US20120302735 Production of soy protein product |
11/29/2012 | US20120302734 Processes for Producing Silk Dope |
11/29/2012 | US20120302733 Selection and characterization of novel plant-derived recombinant human interferons with broad spectrum activity |
11/29/2012 | US20120302732 Chimeric immunoreceptor useful in treating human cancers |
11/29/2012 | US20120302650 Insulin-Like Growth Factor 1 Receptor (IGF1R) Protein SRM/MRM Assay |
11/29/2012 | US20120302627 Method of using adenoviral vectors to induce an immune response |
11/29/2012 | US20120302512 Isolated laminin-421 |
11/29/2012 | US20120302510 Histone deacetylases, and uses related thereto |
11/29/2012 | US20120302509 Compositions and methods to prevent cancer with cupredoxins |
11/29/2012 | US20120302507 Liquid Product of Botulinum Toxin Type A |
11/29/2012 | US20120302506 Maspin-based treatment and prevention of cancer |
11/29/2012 | US20120302503 PEPTIDES FOR PREVENTING OR TREATING A DISEASE OR DISORDER ASSOCIATED WITH CBP OR p300 MISREGULATION, AND METHODS FOR USE AND IDENTIFICATION THEREOF |
11/29/2012 | US20120302498 Insulin like peptides |
11/29/2012 | US20120302495 Insecticidal proteins derived from bacillus thuringiensis |
11/29/2012 | US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists |
11/29/2012 | US20120302492 Antibody Mimetic Scaffolds |
11/29/2012 | US20120302460 Use of Low Affinity Neurotrophin Receptor P75 As Marker for High Differentiation Potential Muscle Stem Cells, Muscle Satellite Cells, And Degenerative Skeletal Muscle Diseases |
11/29/2012 | US20120302452 Comparative ligand mapping from mhc class i positive cells |
11/29/2012 | US20120301962 Vitronectin-derived cell culture substrate and uses thereof |
11/29/2012 | US20120301921 Compositions and methods of treating disease with fgfr fusion proteins |
11/29/2012 | US20120301912 Methods, compositions and kits for assaying mitochondrial function |
11/29/2012 | US20120301871 Comparative ligand mapping from mhc positive cells |
11/29/2012 | US20120301535 Combination peptide-nanoparticles and delivery systems incorporating same |
11/29/2012 | US20120301518 Biocompatible and biodegradable elastomeric polymers |
11/29/2012 | US20120301514 Development of bioactive electrospun coatings for biomedical applications |
11/29/2012 | US20120301504 Influenza Virus Recombinant Proteins |
11/29/2012 | US20120301503 Influenza hemagglutinin and neuraminidase variants |
11/29/2012 | US20120301499 Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use |
11/29/2012 | US20120301497 Plasmodium vivax Hybrid Circumsporozoite Protein and Vaccine |
11/29/2012 | US20120301496 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
11/29/2012 | US20120301495 Antigen peptide and use thereof |
11/29/2012 | US20120301493 Applications of the protein muns and the derivates thereof |
11/29/2012 | US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof |
11/29/2012 | US20120301474 Compositions and methods for immunization against drug resistant acinetobacter baumannii |
11/29/2012 | US20120301446 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders |
11/29/2012 | US20120301434 Antibacterial polypeptides and use thereof |
11/29/2012 | US20120301393 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
11/29/2012 | DE112010000838T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Plants having enhanced yield-related traits and methods of making the same |
11/29/2012 | CA2837126A1 Canine influenza recombinant virus, preparation method therefor and application thereof |
11/29/2012 | CA2837104A1 Amylin peptides and derivatives and uses thereof |
11/29/2012 | CA2837096A1 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use |
11/29/2012 | CA2836873A1 Deimmunized serum-binding domains and their use for extending serum half-life |
11/29/2012 | CA2836815A1 Plants having enhanced abiotic stress resistance |
11/29/2012 | CA2836775A1 Chloroplast transit peptides and methods of their use |
11/29/2012 | CA2835816A1 Novel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein |
11/29/2012 | CA2835517A1 Method for the diagnosis of rheumatoid arthritis |
11/29/2012 | CA2834660A1 Universal primers and the use thereof for the detection and identification of amphibia/fish species |
11/29/2012 | CA2833400A1 Expression of caleosin in recombinant oleaginous microorganisms to increase oil content therein |
11/28/2012 | EP2527841A1 Methods for the diagnosis of rheumatoid arthritis |
11/28/2012 | EP2527839A2 Methods and reagents for detecting susceptilbility to transplant related mortality |
11/28/2012 | EP2527837A1 Methods of inhibiting cell death or inflammation in a mammal |
11/28/2012 | EP2527447A1 Agents and methods for diagnosing stress |
11/28/2012 | EP2527446A1 Agents and methods for diagnosing stress |
11/28/2012 | EP2527435A2 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT 8) gene expression |
11/28/2012 | EP2527424A1 Recombinant expression of soluble Interferon |
11/28/2012 | EP2527362A1 Nucleic acid molecules encoding wrinkled1-like polypeptides and methods of use in plants |
11/28/2012 | EP2527361A1 Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection |
11/28/2012 | EP2526972A1 A conjugate of an antibody against CD4 and antifusogenic peptides |
11/28/2012 | EP2526968A2 Nogo receptor antagonists |
11/28/2012 | EP2526966A2 Herpes simplex virus combined subunit vaccines and methods of use thereof |
11/28/2012 | EP2526962A1 Therapeutic application of Kazal-type serine protease inhibitors |
11/28/2012 | EP2526959A1 Treatment of pulmonary disease conditions |
11/28/2012 | EP2526199A2 Methods of generating zinc finger nucleases having altered activity |
11/28/2012 | EP2526194A1 Methods for intracellular delivery of nucleic acids |
11/28/2012 | EP2526185A1 BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID |
11/28/2012 | EP2526119A2 Engineered opsonin for pathogen detection and treatment |
11/28/2012 | EP2526117A2 Process for preparing fgf-21 with low degree of o-glycosylation |
11/28/2012 | EP2526115A1 Purification of blood coagulation factors |
11/28/2012 | EP2525833A2 Stable growth hormone compounds |
11/28/2012 | EP2525824A2 Inhibition of axl signaling in anti-metastatic therapy |
11/28/2012 | EP2525819A2 Immunotherapy compositions and methods of treatment |
11/28/2012 | EP2525818A2 Immunogenic influenza composition |
11/28/2012 | EP2525806A1 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity |
11/28/2012 | CN1989153B High affinity ny-eso t cell receptor |
11/28/2012 | CN1930184B Novel TAT complexes, and vaccines comprising them |
11/28/2012 | CN1910274B Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
11/28/2012 | CN102803967A Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma |
11/28/2012 | CN102803487A Cancer antigen helper peptide |
11/28/2012 | CN102803485A Modified biotin-conjugated protein |
11/28/2012 | CN102803292A Control Of Protein Glycosylation And Compositions And Methods Relating Thereto |
11/28/2012 | CN102803291A Plants having enhanced yield-related traits and/or enhanced abiotic stress tolerance and a method for making the same |
11/28/2012 | CN102803290A Bacillus strain for increased protein production |
11/28/2012 | CN102803289A Improved optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production |
11/28/2012 | CN102803288A Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
11/28/2012 | CN102803286A Process for production of peptide thioester |
11/28/2012 | CN102802669A Hydrophobins for dispersing active agents |